Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We describe the fabrication and characterization protocols used in our studies of magneto-electrical nanoparticles (MENs) for enabling Personalized Nanomedicine (PNM) from the perspective of fundamental physics and nanoengineering. This approach exploits quantum-mechanical coupling between electric and magnetic fields within MENs. Anti-Cancer and anti-HIV drugs were released on demand.

Abstract

The use of nanoparticles is often considered as an enabling force of personalized nanomedicine (PNM). Using nanoparticles to precisely navigate a drug through the patient's body and control its dosage and composition as well as to detect even minute disease-caused changes in the surrounding cellular microenvironment can make personalized treatment a reality. However, the fundamental physics that underlies the nanoparticles' characteristics in the perspective of the intrinsic interaction with the patient's body in the aforementioned applications is poorly exploited. Our recent discovery of the unprecedented capabilities of magneto-electric nanoparticles (MENs) helps fill this gap. MENs could be used as energy-efficient and dissipation-free field-controlled nano-vehicles for targeted delivery and on-demand release of anti-Cancer and anti-HIV drugs as well as nano-stimulators for field-controlled non-invasive treatment of patients with central nervous system (CNS) disorders. Further, the intrinsic coupling between electric and magnetic forces within MENs enables molecular specificity that provides an entirely new dimension even to conventional state-of-the-art diagnostic methods such as MRI, magnetic nanoparticle imaging (MNI), and PET-CT.

Here, we present detailed fabrication protocols and characterization procedures to study and develop MENs that could be used for targeted drug delivery and on-demand release with no heat dissipation. To demonstrate the new application, we use scanning probe microscopy approaches to directly trace the kinetics of a magneto-electric action used to release AZT 5'-triphosphate (AZTTP), an anti-HIV drug, from 30-nm CoFe2O4-BaTiO3 MENs by applying a DC and low-frequency (below 1000 Hz) AC field. Finally, we present a study to employ MENs for an on-demand targeted treatment of Ovarian Epithelial Cancer with Paclitaxel (Taxol), a popular mitotic inhibitor.

Introduction

Researchers across the globe have long been struggling to find a better way to navigate and dispense the cargo of drugs and/or disease-specific image contrast agents to the damaged tissue or at the site of action with adequately high efficiency and 3-D navigation precision 1. Personalized NanoMedicine (PNM) has recently emerged as a multi-disciplinary field that leverages nanotechnology to achieve these diagnostics and treatment milestones. However, in spite of its unprecedented potential, this field is at its very early stage of development and no viable PNM technologies exist today. The use of nanoparticles is often considered an essentia....

Protocol

1. Magneto-Electric Nanoparticles: Synthesis and Characterization

  1. Prepare CoFe2O4 nanoparticles by hydrothermal method described previously 6.
  2. Dissolve 15 ml of aqueous mixture of 0.058 g of Co(NO3)2.6H20, 0.16 g of Fe(NO3)3.9H20 and 0.2 g of polyvinylpyrrolidone in 5 ml of aqueous 0.9 g sodium borohydride at 120 °C for 12 hours.
  3. Next, prepare the precursor so.......

Representative Results

Qualitative results

FTIR analysis

FTIR analysis of the drug binding and release process was confirmed by performing the measurements at three key stages, 1) before loading the drug on MENs, 2) when the drugs are attached to the MENs surface, 3) after releasing the drugs by remote 44 Oe AC magnetic field strength and 100-Hz frequency. The FTIR results for AZTTP-MENs are shown in Figure 3. These results indicate 30% weaker absorbance of bou.......

Discussion

Below, we discuss the most important aspects one should bear in mind while conducting the above experiments on field-controlled delivery and on-demand release of the drug carried by MENs. These aspects mostly relate to the use of field and power sources according to the described protocols and procedures.

MENs display all the properties that are displayed by the conventional MNs. Therefore, MENs can replace MNs in any existing application, e.g., as drug nano-carriers or contrast.......

Acknowledgements

We acknowledge partial financial support from National Science Foundation (NSF) award # 005084-002, National Institute of Health (NIH) DA # 027049, and Department of Defense (DoD) Defense Microelectronics Activity (DMEA) under contract # H94003-09-2-0904.

....

Materials

NameCompanyCatalog NumberComments
Reagent
Co(NO3)2.6H20Sigma-Aldrich203106-10G
Fe(NO3)3.9H20 Sigma-Aldrich254223-10G
PolyvinylpyrrolidoneSigma-AldrichPVP40-100G
Titanium isopropoxideSigma-Aldrich7560-500ML
BaCO3 Sigma-Aldrich237108-500G
Citric acid Sigma-Aldrich251275-500G
EthanolSigma-Aldrich459844-1L
GMOPfaltz &Bauer25496-72-4
PBS BufferGibco10010-023
AZTTP druge-enzymeAT-013-0170
Paclitaxel DrugInvitrogenP3456
TE bufferFluka93302-500ml
Sodium borohydrideSigma-Aldrich71321-25G
Equipment
SpectrophotometerVarianCary-100
FTIRJasco 4100
AFMVeeco MetrologyNanoscope-IIIa
Helmholtz coilsHome Made
AC GeneratorAgilent33220a
DC Power supplyBK-Precision1660A

References

  1. Varatharajan, L. & Thomas, S.A. The transport of anti-HIV drugs across blood, ÄìCNS interfaces: summary of current knowledge and recommendations for further research. Antiviral research. 82, A99 (2009).
  2. Timko, B.P., Dvir, T., & Kohane, D.S. Remotely triggerable drug delivery systems. Advanced Materials. 22, 4925-4943 (2010).
  3. Saiyed, Z.M., Gandhi, N.H., & Nair, M.P.N. Magnetic nanoformulation of azidothymidine 5,Äô-triphosphate for targeted delivery across the blood,Äìbrain barrier. International journal of nanomedicine. 5, 157 (2010....

Explore More Articles

Nervous System DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsVirus DiseasesImmune System DiseasesPharmaceutical PreparationsTechnologyIndustryand AgricultureEngineering GeneralMagneto electric nanoparticlesTargeted drug DeliveryRemote field triggeringOn demand drug releaseNanomedicinePersonalized Nanomedicine

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved